Drug Induced Movement Disorders
2nd Edition
Published on 24. April 2008
480 pages
978-1-4051-3755-3 (ISBN)
Description
The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.
Reviews / Votes
"This well written comprehensive book provides the reader with goodclinical descriptions of the major movement disorders and withextensively referenced data on studies and trials regarding bothdrugs incriminated in abnormal movements and those useful in theirmanagement." "In conclusion, this comprehensive review of drug-inducedmovement disorders will be extremely useful to every clinician,particularly those interested in the fields of neurology andpsychiatry." Christian Wider, European Neurology, December 5th2005More details
Other editions
Additional editions
Software
01/2008
Wiley
€103.26
No shipping information available
Stewart Factor | Anthony Lang | William Weiner
Drug Induced Movement Disorders
Book
04/2005
2nd Edition
Wiley
€236.50
Shipment within 3-4 weeks
Persons
Dr. Stewart Factor, DO. Professor of Neurology, Riley Family Chairin Parkinson's Disease, Director, Parkinson's Disease andMovement Disorder Program, Albany Medical Center
Dr. Anthony E. Lang, MD. Movement Disorder Clinic, TorontoWestern Hospital
Dr. William J. Weiner, MD. Chair, Department ofNeurology, University of Maryland School of Medicine
Content
Section 1: General Considerations.
Chapter 1: Movement Disorders: Approach, Definitions anddifferential Diagnosis.
Martin Cloutier, Anthony E. Lang.
Chapter 2: Rating Scales for Movement Disorders.
Wonodi I, Hong EH, Avila MT, Gunvant Thaker.
Chapter 3: Spontaneous movement disorders in psychiatricpatients.
Irene Richard, Christopher O'Brien, RogerKurlan.
Section 2: Antipsychotics.
Chapter 4: Pharmacology of typical and atypical agents.
Gary Remington, Shitij Kapur.
Chapter 5: Acute Drug-induced Dystonia.
Michael F. Mazurek, Patricia I. Rosebush.
Chapter 6: Drug-Induced Parkinsonism.
Joseph H. Friedman, Martha E. Trieschmann, Hubert H.Fernandez.
Chapter 7: Acute Akathisia.
Author: Lenard A. Adler, John Rotrosen, Burt Angrist.
Chapter 8: Neuroleptic Malignant Syndrome.
Stewart A. Factor.
Chapter 9: Classical Tardive Dyskinesia.
Thomas M. Hyde, MD, Jose A. Apud, Whitney C. Fisher, MichaelF. Egan.
Chapter 10: Tardive dyskinesia Variants.
Skidmore F, Weiner W, Burke R.
Chapter 11: Movement Disorders caused by atypicalantipsychotics.
Karen E. Anderson.
Chapter 12: Commentary: Is Tardive dyskinesiadisappearing?James Lohr, MD.
.
.
Section 3: Dopaminomimetic Drugs.
Chapter 13: Dyskinesia induced by levodopa and dopamine agonistsin Parkinson's disease.
John G. Nutt, Matthew Brodsky.
Chapter 14: Stimulant Drugs.
Anthony E. Munson, Juan Sanchez-Ramos, William JWeiner.
Section 5: Other Drugs.
Chapter 15: Antidepressants.
Marie L. Moro-de-Casillas, David E. Riley.
Chapter 16: Anticonvulsants.
John C. Morgan, Madeline Harrison.
Chapter 17: Miscellaneous Drugs.
Daniel Tarsy
